Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Has Consensus Target Price of $21.67 According to Brokerages

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fifteen research firms that are covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $21.92.

A number of analysts have commented on the company. Citizens Jmp boosted their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research report on Wednesday, July 22nd. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Wells Fargo & Company increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday. Deutsche Bank reiterated a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Finally, Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th.

Read Our Latest Research Report on SBRA

Insider Activity

In related news, CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael Foster sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $20.98, for a total value of $209,800.00. Following the sale, the director directly owned 72,834 shares in the company, valued at approximately $1,528,057.32. This represents a 12.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.09% of the stock is owned by insiders.

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors have recently modified their holdings of the company. Rush Island Management LP purchased a new stake in shares of Sabra Healthcare REIT in the 1st quarter valued at approximately $30,735,000. William Blair Investment Management LLC purchased a new stake in shares of Sabra Healthcare REIT in the third quarter worth approximately $16,545,000. Russell Investments Group Ltd. lifted its position in shares of Sabra Healthcare REIT by 70.2% in the third quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock worth $36,615,000 after purchasing an additional 765,527 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of Sabra Healthcare REIT by 161.0% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 926,972 shares of the real estate investment trust’s stock worth $18,280,000 after purchasing an additional 571,743 shares during the period. Finally, BROOKFIELD Corp ON purchased a new position in Sabra Healthcare REIT during the first quarter valued at approximately $9,710,000. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Up 1.8%

Shares of NASDAQ:SBRA opened at $20.62 on Friday. The company has a market cap of $5.40 billion, a price-to-earnings ratio of 73.65, a PEG ratio of 1.76 and a beta of 0.68. The firm’s 50-day simple moving average is $19.86 and its 200-day simple moving average is $20.07. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.86. Sabra Healthcare REIT has a fifty-two week low of $17.53 and a fifty-two week high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). The firm had revenue of $249.57 million for the quarter, compared to analysts’ expectations of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. The company’s revenue for the quarter was up 31.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.38 earnings per share. As a group, equities research analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT’s payout ratio is presently 428.57%.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.

Recommended Stories

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.